EA201890534A1 - Новые аннелированные феноксиацетамиды - Google Patents
Новые аннелированные феноксиацетамидыInfo
- Publication number
- EA201890534A1 EA201890534A1 EA201890534A EA201890534A EA201890534A1 EA 201890534 A1 EA201890534 A1 EA 201890534A1 EA 201890534 A EA201890534 A EA 201890534A EA 201890534 A EA201890534 A EA 201890534A EA 201890534 A1 EA201890534 A1 EA 201890534A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- formula
- phenoxycetamides
- anneled
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
- C07C53/18—Halogenated acetic acids containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Abstract
Настоящее изобретение относится к соединениям формулы (I)в которой R, R, R, и Zимеют одно из значений, указанных в описании, или к их фармацевтически приемлемой соли, к применению соединений формулы (I) в качестве лекарственного средства, к фармацевтической композиции, содержащей по меньшей мере одно соединение формулы (I), a также к комбинациям лекарственных средств, содержащих одно или большее количество соединений формулы (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/069152 WO2017028927A1 (en) | 2015-08-20 | 2015-08-20 | Novel annelated phenoxyacetamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201890534A1 true EA201890534A1 (ru) | 2018-09-28 |
| EA035738B1 EA035738B1 (ru) | 2020-08-03 |
Family
ID=54065852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201890534A EA035738B1 (ru) | 2015-08-20 | 2015-08-20 | Аннелированные феноксиацетамиды |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP3298022B1 (ru) |
| JP (1) | JP6620171B2 (ru) |
| KR (1) | KR20180044333A (ru) |
| CN (1) | CN108200769B (ru) |
| AU (1) | AU2015406100B2 (ru) |
| BR (1) | BR112018001035A2 (ru) |
| CA (1) | CA2996087A1 (ru) |
| CO (1) | CO2018001700A2 (ru) |
| CY (1) | CY1122077T1 (ru) |
| DK (1) | DK3298022T3 (ru) |
| EA (1) | EA035738B1 (ru) |
| ES (1) | ES2739893T3 (ru) |
| HR (1) | HRP20191339T1 (ru) |
| HU (1) | HUE046014T2 (ru) |
| IL (1) | IL257136B (ru) |
| LT (1) | LT3298022T (ru) |
| ME (1) | ME03534B (ru) |
| MX (1) | MX370598B (ru) |
| MY (1) | MY194711A (ru) |
| PH (1) | PH12018500378A1 (ru) |
| PL (1) | PL3298022T3 (ru) |
| PT (1) | PT3298022T (ru) |
| RS (1) | RS59169B1 (ru) |
| SA (1) | SA518390920B1 (ru) |
| SI (1) | SI3298022T1 (ru) |
| UA (1) | UA121414C2 (ru) |
| WO (1) | WO2017028927A1 (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610854D0 (en) * | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
| GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
| CN116438200A (zh) | 2020-09-10 | 2023-07-14 | 普雷西里克斯公司 | 针对fap的抗体片段 |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| WO2023213801A1 (en) | 2022-05-02 | 2023-11-09 | Precirix N.V. | Pre-targeting |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011079087A1 (en) * | 2009-12-23 | 2011-06-30 | Glaxo Group Limited | Enac blockers |
| EP3022196B1 (en) * | 2013-07-15 | 2017-09-06 | Boehringer Ingelheim International GmbH | Novel benzimidazolium compounds |
| WO2015007516A1 (en) * | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Novel 5-substituted benzimidazolium compounds |
| JP6461133B2 (ja) * | 2013-07-15 | 2019-01-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規４置換及び５置換ベンゾイミダゾリウム化合物 |
-
2015
- 2015-08-20 CN CN201580083568.7A patent/CN108200769B/zh active Active
- 2015-08-20 CA CA2996087A patent/CA2996087A1/en not_active Abandoned
- 2015-08-20 EA EA201890534A patent/EA035738B1/ru not_active IP Right Cessation
- 2015-08-20 ES ES15760394T patent/ES2739893T3/es active Active
- 2015-08-20 PT PT15760394T patent/PT3298022T/pt unknown
- 2015-08-20 MY MYPI2018000198A patent/MY194711A/en unknown
- 2015-08-20 KR KR1020187007950A patent/KR20180044333A/ko unknown
- 2015-08-20 JP JP2017564088A patent/JP6620171B2/ja active Active
- 2015-08-20 WO PCT/EP2015/069152 patent/WO2017028927A1/en active Application Filing
- 2015-08-20 AU AU2015406100A patent/AU2015406100B2/en not_active Ceased
- 2015-08-20 SI SI201530828T patent/SI3298022T1/sl unknown
- 2015-08-20 DK DK15760394.5T patent/DK3298022T3/da active
- 2015-08-20 ME MEP-2019-247A patent/ME03534B/me unknown
- 2015-08-20 HU HUE15760394A patent/HUE046014T2/hu unknown
- 2015-08-20 LT LTEP15760394.5T patent/LT3298022T/lt unknown
- 2015-08-20 BR BR112018001035-9A patent/BR112018001035A2/pt active Search and Examination
- 2015-08-20 UA UAA201802620A patent/UA121414C2/uk unknown
- 2015-08-20 RS RSP20191100 patent/RS59169B1/sr unknown
- 2015-08-20 PL PL15760394T patent/PL3298022T3/pl unknown
- 2015-08-20 MX MX2018001945A patent/MX370598B/es active IP Right Grant
- 2015-08-20 EP EP15760394.5A patent/EP3298022B1/en active Active
-
2018
- 2018-01-24 IL IL257136A patent/IL257136B/en unknown
- 2018-02-13 SA SA518390920A patent/SA518390920B1/ar unknown
- 2018-02-20 CO CONC2018/0001700A patent/CO2018001700A2/es unknown
- 2018-02-20 PH PH12018500378A patent/PH12018500378A1/en unknown
-
2019
- 2019-07-24 HR HRP20191339TT patent/HRP20191339T1/hr unknown
- 2019-09-05 CY CY20191100932T patent/CY1122077T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| PH12018500591A1 (en) | Heterocyclic compounds and uses thereof | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| EA202090486A2 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
| EA201792421A1 (ru) | Амидозамещенные производные циклогексана | |
| EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
| EA201690598A1 (ru) | Аминогетероарил бензамиды в качестве ингибиторов киназы | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| EA202090688A1 (ru) | Бис-амидные соединения, активирующие саркомер, и варианты их применения | |
| MX2017014035A (es) | Formas solidas novedosas. | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| EA201690888A1 (ru) | Новые гетероциклические соединения | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201600434A1 (ru) | Применение производных бензимидазолпролина | |
| EA201692298A1 (ru) | Производные карбоксамидов | |
| EA201692300A1 (ru) | Производные карбоксамида | |
| EA201791432A1 (ru) | Композиции на основе пролекарства монометилфумарата | |
| EA201600394A1 (ru) | Трициклические соединения пиперидина | |
| EA201792425A1 (ru) | Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз | |
| EA201591649A1 (ru) | Составы с органическими соединениями | |
| EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
| EA201692270A1 (ru) | Производные нафтиридиндиона |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TJ TM |